Eli Lilly joins forces with China tech giant to expand obesity drug market
Friday, 29 August 2025 () Eli Lilly has partnered with a leading Chinese tech company, JD Health to fast-track its presence in China’s rapidly expanding obesity drug market, boosting the company’s global growth in the weight-loss sector. Eli Lilly’s move into the obesity drug market is reshaping the global pharma landscape. After the success of drugs like Zepbound (tirzepatide) and […]
Friday, 29 August 2025 ()
Eli Lilly has partnered with a leading Chinese tech company, JD Health to fast-track its presence in China’s rapidly expanding obesity drug market, boosting the company’s global growth in the weight-loss sector. Eli Lilly’s move into the obesity drug market is reshaping the global pharma landscape. After the success of drugs like Zepbound (tirzepatide) and […]